← Back to headlines
OraSure Projects H2 2026 Revenue Growth with New FDA-Submitted Diagnostics
OraSure Technologies anticipates a significant revenue increase in the second half of 2026, driven by the planned launch of two new diagnostic products that have been submitted to the FDA.
26 Feb, 01:18 — 26 Feb, 01:18
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Red tide returns to western Pangasinan, says BFAR
just now
PGI Warns of Life-Threatening Risks of Untreated Sleep Apnoea
19m ago
Halloumi is at risk from foot-and-mouth - eKathimerini.com
31m ago
India’s youth rank 60th in mental well-being across 84 countries, elderly at rank 49, says global report
38m ago